Jesy Nelson, the 34-year-old singer and former Little Mix star, has achieved a major breakthrough in her tireless campaign to protect newborns from Spinal Muscular Atrophy (SMA) after the heartbreaking diagnosis of her own twin daughters. On Friday, Jesy shared that the UK Government confirmed the petition to add SMA to newborn screening in England will now be debated in Parliament on 22 June 2026 — a major step forward for the SMA community and a deeply personal victory for the star.
In January, Jesy revealed that her now one-year-old twins, Ocean and Story, had been diagnosed with SMA Type 1, a rare and devastating muscle-wasting disease. The diagnosis came late, leaving the babies reliant on specialist equipment to breathe at night, feeding tubes, and the prospect that they may never walk. The singer described the moment as “devastating” but quickly channeled her grief into advocacy, determined to prevent other families from facing the same ordeal.
Jesy’s campaign has focused on pushing the NHS to expand its newborn screening programme to include SMA. Currently, standard “heel prick” testing screens for just 10 treatable conditions, including cystic fibrosis. Thanks to Jesy’s persistence, however, the government has pledged that more than 400,000 babies will now be screened for SMA starting October 2026, nearly a year earlier than originally planned.
The singer took to Instagram to celebrate the news, writing: “A big step forward for SMA. ISE have announced to start screening for SMA in England will now begin in October 2026. I am so proud as this is a major milestone for the SMA community.” The pilot scheme will offer crucial early detection, giving newborns a fighting chance to receive timely treatment that could improve quality of life and potentially extend life expectancy.
Jesy’s advocacy follows a series of harrowing experiences caring for her daughters. In interviews, she has described the emotional toll of daily medical routines, which involve monitoring, therapy, and procedures that can leave the babies crying and distressed. “Every day is so full-on — I can speak about it, but I’ll never be able to explain how intense it is until you see it,” she said. Despite the challenges, Jesy emphasizes the resilience and strength of her children, insisting, “My girls are the strongest, most resilient babies and I really believe that they are going to defy all the odds.”
The singer’s determination to campaign for SMA screening is deeply personal. In a conversation on Jamie Laing’s Great Company podcast, she explained: “Spinal muscular atrophy is a muscular wasting disease, so they don’t have a gene that we all have in our body. Their muscles are now deteriorating and wasting away, which affects breathing, swallowing, everything. Without treatment, they would die before the age of two.” Her decision to speak publicly about the condition has helped shine a spotlight on a disease that is often overlooked and under-diagnosed.
The SMA campaign is now gaining parliamentary attention, with calls for the Health Secretary to overrule committee guidance and make treatment more widely accessible on the NHS. The debate on 22 June will be crucial, with Jesy’s advocacy and public profile helping to amplify the voices of families affected by SMA. The decision to implement widespread newborn screening could save lives, prevent late diagnoses, and give families critical early intervention.
Jesy’s journey is also a testament to resilience and professionalism. Despite her daughters’ diagnosis and the daily intensity of caregiving, she has continued filming her Prime Video series, using her platform to inspire change while balancing family life. “When the girls got their diagnosis, we decided we wanted to continue filming,” Jesy said. “As hard as it was, we were like, ‘You know what? There’s a reason you guys are here, and we’ve got to make the best out of this situation.’”
Her campaign has already had tangible effects. Last month, she shared the joy of learning that the NHS would roll out SMA testing for newborns. Wes Streeting, the Health Secretary, confirmed in a letter to Jesy and Giles Lomax, CEO of SMA UK, that the in-service evaluation of SMA screening would be implemented faster and cover a wider geographic area. The screening is now expected to begin in October 2026, nearly three months earlier than initially planned, ensuring babies at risk can receive treatment as soon as possible.
Jesy’s advocacy is remarkable not only for its impact but for its transparency. She has openly discussed the emotional strain of caring for her daughters, including the pain of watching them endure medical interventions and navigating the complex realities of raising children with a life-limiting condition. Her willingness to share these experiences has sparked a national conversation about the importance of early diagnosis, newborn screening, and support for families affected by SMA.
SMA itself is a rare, genetic condition that attacks motor neurons in the spinal cord, causing progressive muscle wasting and weakness. Type 1 SMA, the most severe form, is evident at birth, preventing babies from sitting independently and often leading to death by age five without treatment. The disease varies in severity, with Type 2 causing inability to stand, Type 3 causing difficulty rising from sitting, and Type 4 typically appearing in adulthood. Early detection is critical, and Jesy’s campaign has underscored the life-changing potential of newborn screening.
The singer’s personal connection to the issue — having twins diagnosed with Type 1 SMA — has given her campaign authenticity and urgency. Her story has mobilized public support, drawn media attention, and ensured that Parliament will now formally debate the inclusion of SMA testing in routine newborn screening. This represents a historic moment for SMA awareness and advocacy, potentially transforming the care landscape for thousands of families in the UK.
Despite the heartbreaking prognosis for Ocean and Story — who may never walk and require specialist equipment — Jesy remains optimistic and determined. She continues to highlight their strength and resilience, insisting that the twins are “defying all the odds” with the care and treatment they now receive. Her voice as a public figure is helping drive policy change and public awareness, ensuring that SMA is no longer overlooked in newborn screening programmes.
Jesy Nelson’s campaign demonstrates the power of celebrity advocacy combined with lived experience. By leveraging her platform, she has transformed a personal tragedy into a national movement, creating hope for families affected by SMA and raising awareness about the importance of early detection and intervention. Her determination, courage, and transparency are inspiring both within the entertainment industry and among the general public.
As Parliament prepares to debate the inclusion of SMA in newborn screening, Jesy’s achievement is a milestone not only in her personal journey but for the entire SMA community. With over 400,000 babies expected to be screened in England starting October 2026, Jesy’s relentless campaigning has already begun to change lives — and will likely continue to save countless others.
Her story is one of heartbreak, resilience, and advocacy — a reminder of the profound difference one person can make when using their voice for a greater cause. Through her music, media presence, and public advocacy, Jesy Nelson has transformed her personal experience into hope, action, and a tangible milestone in the fight against SMA.
